Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)

NCT00167518 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Sydney